Literature DB >> 15856171

Multicenter study of the multiple organ dysfunction syndrome in intensive care units: the usefulness of Sequential Organ Failure Assessment scores in decision making.

L Cabré1, J Mancebo, J F Solsona, P Saura, I Gich, L Blanch, G Carrasco, M C Martín.   

Abstract

OBJECTIVE: This study examined the incidence and mortality of multiple organ dysfunction syndrome (MODS) in intensive care units, evaluated the limitation of life support in these patients, and determined whether daily measurement of the Sequential Organ Failure Assessment (SOFA) is useful for decision making. DESIGN AND
SETTING: Prospective, observational study in 79 intensive care units. PATIENTS AND PARTICIPANTS: Of the 7,615 patients admitted during a 2-month period we found 1,340 patients to have MODS. MEASUREMENTS AND
RESULTS: We recorded mortality and length of stay in the intensive care unit and the hospital and the maximum and minimum total SOFA scores during MODS. Limitation of life support in MODS patients was also evaluated. Stepwise logistic regression was used to determine the factors predicting mortality. The in-hospital mortality rate in patients with MODS was 44.6%, and some type of limitation of life support was applied in 70.6% of the patients who died. The predictive model maximizing specificity included the following variables: maximum SOFA score, minimum SOFA score, trend of the SOFA for 5 consecutive days, and age over 60 years. The model diagnostic yield was: specificity 100%, sensitivity 7.2%, positive predictive value 100%, and negative predictive value 57.3%; the area under the receiver operating characteristic curve was 0.807.
CONCLUSIONS: This model showed that in our population with MODS those older than 60 years and with SOFA score higher than 9 for at least 5 days were unlikely to survive.

Entities:  

Mesh:

Year:  2005        PMID: 15856171     DOI: 10.1007/s00134-005-2640-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

1.  Withholding and withdrawal of life support from the critically ill.

Authors:  N G Smedira; B H Evans; L S Grais; N H Cohen; B Lo; M Cooke; W P Schecter; C Fink; E Epstein-Jaffe; C May
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

2.  Limitation of life support: frequency and practice in a London and a Cape Town intensive care unit.

Authors:  J S Turner; W L Michell; C J Morgan; S R Benatar
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

3.  Prognosis in acute organ-system failure.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

4.  Application of SOFA score to trauma patients. Sequential Organ Failure Assessment.

Authors:  M Antonelli; R Moreno; J L Vincent; C L Sprung; A Mendoça; M Passariello; L Riccioni; J Osborn
Journal:  Intensive Care Med       Date:  1999-04       Impact factor: 17.440

5.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM.

Authors:  R Moreno; J L Vincent; R Matos; A Mendonça; F Cantraine; L Thijs; J Takala; C Sprung; M Antonelli; H Bruining; S Willatts
Journal:  Intensive Care Med       Date:  1999-07       Impact factor: 17.440

6.  Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill.

Authors:  Ville Pettilä; Markus Pettilä; Seppo Sarna; Petri Voutilainen; Olli Takkunen
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

7.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

8.  Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients.

Authors:  S Lemeshow; D Teres; J Klar; J S Avrunin; S H Gehlbach; J Rapoport
Journal:  JAMA       Date:  1993-11-24       Impact factor: 56.272

9.  End-of-life decisions in intensive care units: attitudes of physicians in an Italian urban setting.

Authors:  Alberto Giannini; Adriano Pessina; Enrico Maria Tacchi
Journal:  Intensive Care Med       Date:  2003-09-11       Impact factor: 17.440

Review 10.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

View more
  26 in total

1.  Development of a triage protocol for critical care during an influenza pandemic.

Authors:  Michael D Christian; Laura Hawryluck; Randy S Wax; Tim Cook; Neil M Lazar; Margaret S Herridge; Matthew P Muller; Douglas R Gowans; Wendy Fortier; Frederick M Burkle
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

2.  Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator-associated pneumonia, ethics, haematology and haemostasis, ICU organisation and scoring, brain injury.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker
Journal:  Intensive Care Med       Date:  2006-02-17       Impact factor: 17.440

3.  End-of-life care in Spain: legal framework.

Authors:  Lluís Cabré; María Casado; Jordi Mancebo
Journal:  Intensive Care Med       Date:  2008-09-12       Impact factor: 17.440

4.  Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.

Authors:  T Akahoshi; H Sugimori; N Kaku; K Tokuda; T Nagata; E Noda; M Morita; M Hashizume; Y Maehara
Journal:  Eur J Trauma Emerg Surg       Date:  2014-11-20       Impact factor: 3.693

5.  The value of vital sign trends for detecting clinical deterioration on the wards.

Authors:  Matthew M Churpek; Richa Adhikari; Dana P Edelson
Journal:  Resuscitation       Date:  2016-02-16       Impact factor: 5.262

6.  Serial Daily Organ Failure Assessment Beyond ICU Day 5 Does Not Independently Add Precision to ICU Risk-of-Death Prediction.

Authors:  Andre L Holder; Elizabeth Overton; Peter Lyu; Jordan A Kempker; Shamim Nemati; Fereshteh Razmi; Greg S Martin; Timothy G Buchman; David J Murphy
Journal:  Crit Care Med       Date:  2017-12       Impact factor: 7.598

7.  Health-related quality of life as a prognostic factor of survival in critically ill patients.

Authors:  Sebastián Iribarren-Diarasarri; Felipe Aizpuru-Barandiaran; Tomás Muñoz-Martínez; Angel Loma-Osorio; Marianela Hernández-López; José María Ruiz-Zorrilla; Carlos Castillo-Arenal; Juan Luis Dudagoitia-Otaolea; Sergio Martínez-Alutiz; Cristina Vinuesa-Lozano
Journal:  Intensive Care Med       Date:  2009-01-29       Impact factor: 17.440

Review 8.  Clinical review: scoring systems in the critically ill.

Authors:  Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care       Date:  2010-03-26       Impact factor: 9.097

9.  Glasgow Coma Scale score dominates the association between admission Sequential Organ Failure Assessment score and 30-day mortality in a mixed intensive care unit population.

Authors:  Daniel B Knox; Michael J Lanspa; Cristina M Pratt; Kathryn G Kuttler; Jason P Jones; Samuel M Brown
Journal:  J Crit Care       Date:  2014-05-28       Impact factor: 3.425

Review 10.  Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review.

Authors:  Lilian Minne; Ameen Abu-Hanna; Evert de Jonge
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.